Literature DB >> 16491627

S0307. Phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16491627

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307.

Authors:  Julie R Gralow; William E Barlow; Alexander H G Paterson; Jieling L M'iao; Danika L Lew; Alison T Stopeck; Daniel F Hayes; Dawn L Hershman; Mark M Schubert; Mark Clemons; Catherine H Van Poznak; Elizabeth C Dees; James N Ingle; Carla I Falkson; Anthony D Elias; Michael J Messino; Jeffrey H Margolis; Shaker R Dakhil; Helen K Chew; Kim Z Dammann; Jeffrey S Abrams; Robert B Livingston; Gabriel N Hortobagyi
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506

Review 2.  A national portfolio of bone oncology trials-The Canadian experience in 2012.

Authors:  I Kuchuk; D Simos; C L Addison; M Clemons
Journal:  J Bone Oncol       Date:  2012-10-17       Impact factor: 4.072

Review 3.  Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma.

Authors:  Hélène Grégoire; Loris Roncali; Audrey Rousseau; Michel Chérel; Yves Delneste; Pascale Jeannin; François Hindré; Emmanuel Garcion
Journal:  Front Pharmacol       Date:  2020-04-08       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.